Analys

QLUCORE: CE headwind overshadows structural growth story

2022-09-01• Analys, Research

While the business side of Qlucore is moving steady forward, with 67% growth, two new Qlucore Insight license deals and an expansion of the...

Read More →

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

2022-08-30• Analys

Besides completing a capital raise in these challenging market conditions, KebNi enjoys strong business momentum with new antenna orders...

Read More →

DLABORATORY: Welcome boost from booming attention on power grid stability

2022-08-26• Analys

The rise of network stability and electricity security on the public agenda has finally started to translate into a material rise in...

Read More →

HILBERT GROUP: Light at the end of the tunnel | Read our interview with Niclas Sandström, CEO Hilbert Group

2022-08-25• Analys, Research

In the first half of 2022 we have seen the collapse of Luna, several big crypto companies struggle and both Bitcoin and Ether price tumble...

Read More →

MEDS: Strong momentum in pharmacy market’s transition to online

2022-08-23• Analys

With a proprietary tech platform, 80-130% retention rates and a Net Promotor Score (NPS) of 72/100, MEDS is on track to capture the SEK...

Read More →

SWEDISH STIRLING: Protracted negotiations shades short term outlook – while long term case remains strong

2022-08-23• Analys, Research

Strengthened by the support of renowned names in the upcoming green preference share issue Swedish Stirling now stands ready to deliver to...

Read More →

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

2022-08-18• Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More →

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

2022-08-10• Analys, Research

As a result of the ongoing preparations of the DFS for Dannemora, GRANGEX now reports an upwards revision of the known and indicated...

Read More →

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

2022-08-05• Analys

With the new CEO in place, Simris has now set course to pursue the most high value application area for microalgae, the biopharma sector in...

Read More →

AGTIRA: Capitalizing on rising global focus on food tech

2022-06-30• Analys, Research

Agtira continues to build momentum in its roll-out. The LOI with Greenfood now has turned into a framework agreement for the construction...

Read More →

QLUCORE: CE headwind overshadows structural growth story

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

DLABORATORY: Welcome boost from booming attention on power grid stability

HILBERT GROUP: Light at the end of the tunnel | Read our interview with Niclas Sandström, CEO Hilbert Group

MEDS: Strong momentum in pharmacy market’s transition to online

SWEDISH STIRLING: Protracted negotiations shades short term outlook – while long term case remains strong

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

AGTIRA: Capitalizing on rising global focus on food tech

Widmark Research

CONTACT